Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP Plus Bevacizumab in DLBCL
NCT00788606Phase 2Terminated
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- May 2008
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in diffuse large B-cell lymphoma (DLBCL), sponsored by Royal Marsden NHS Foundation Trust. Started May 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00788606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788606.